통화 / DYN
DYN: Dyne Therapeutics Inc
13.49
USD
0.26
(1.89%)
DYN 환율이 오늘 -1.89%로 변동했습니다. 당일 이 종목은 저가가 13.33이고 고가는 13.87이었습니다.
Dyne Therapeutics Inc 변동을 참고하세요. 실시간 쿼트는 여러분이 시장 변동에 빠르게 대처하는데에 도움이 될 것입니다. 차트 주기를 전환하여 환율의 추세와 변동을 분, 시간, 일, 주 및 월별로 모니터링할 수 있습니다. 이 정보를 사용하여 시장 변화를 예측하고 정보에 입각한 거래 결정을 내리십시오.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
DYN News
- Dyne Therapeutics stock rises after Raymond James upgrade to Strong Buy
- Raymond James upgrades Dyne Therapeutics stock to Strong Buy on DMD therapy outlook
- Avidity Biosciences stock soars on Novartis takeover approach report
- Dyne Therapeutics stock gains as DYNE-251 receives FDA breakthrough designation
- Dyne Therapeutics stock rises after FDA grants breakthrough therapy status
- Does Dyne Therapeutics (DYN) Have the Potential to Rally 285.57% as Wall Street Analysts Expect?
- Stifel lowers Dyne Therapeutics stock price target to $36 on endpoint changes
- These Analysts Lower Their Forecasts On Dyne Therapeutics Following Q2 Loss - Dyne Therapeutics (NASDAQ:DYN)
- Dyne Reports Wider Loss in Fiscal Q2
- Dyne Therapeutics extends cash runway as it advances key drug programs
- Bernstein lowers Dyne Therapeutics stock price target on equity raise
- Tesla, Progress Software, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - AeroVironment (NASDAQ:AVAV), Dyne Therapeutics (NASDAQ:DYN)
- Tesla, AeroVironment and Progress Software fall premarket; MSC Industrial rises
- Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Argo Blockchain (NASDAQ:ARBK), Applied DNA Sciences (NASDAQ:APDN)
- Dyne Therapeutics stock falls after announcing $200 million share offering
- Dyne Therapeutics secures $275 million loan facility from Hercules Capital
- Jones Trading initiates Dyne Therapeutics stock with buy rating
- Avidity, Dyne get Bernstein ratings as oligonucleotide muscle trials advance
- Dyne Therapeutics: Emergence As A Superior DM1/DMD Player Warrants Rating Upgrade (DYN)
- H.C. Wainwright reiterates buy rating on Dyne Therapeutics stock
- Why Is Dyne Therapeutics Stock Trading Lower On Tuesday? - Dyne Therapeutics (NASDAQ:DYN)
- Dyne Therapeutics stock falls after updated plan for accelerated approval in DM1
- Dyne’s DM1 treatment receives FDA breakthrough designation
- Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET
일일 변동 비율
13.33
13.87
년간 변동
6.36
37.08
- 이전 종가
- 13.75
- 시가
- 13.75
- Bid
- 13.49
- Ask
- 13.79
- 저가
- 13.33
- 고가
- 13.87
- 볼륨
- 5.062 K
- 일일 변동
- -1.89%
- 월 변동
- 39.65%
- 6개월 변동
- -1.24%
- 년간 변동율
- -51.40%
31 8월, 일요일